miércoles, 29 de enero de 2025

WORLD NEGLAECTED TROPICAL DISEASES DAY (NTD) 2025 - Lymphostatic Elephantiasis - Organic Lymphatic Vessel Disease - Lymphatic Filariasis - Podoconiosis - Mossy Foot Disease - Puffy Foot Syndrome - Pediatric and Primary Lymphedema - Secondary Lymphedema - Best Practices Guidelines - Preventive Medicine - Awareness Campaign

 


LYMPHOSTATIC ELEPHANTIASIS



Lymphedema is a chronic inflammatory disease of the skin due to valvular impairment (Organic Lymphatic Vascular Disease) resulting in a progressive lymph fluid buildup. Elephantiasis (Stage III lymphedema) results in the majority of cases, from non-treatment or under-treatment of lymphedema, which leads to consequent severe disfigurement, cutaneous complications, infections, physical disability, and low quality of life. Read more about the signs, symptoms, and complications of lymphedema HERE.



Episodes of acute dermatolymphangioadenitis (Infectious Cellulitis) and angiosarcoma (lymphangiosarcoma) are among the most severe clinical consequences of lymphedema, which can even be a direct cause of mortality. Read more about the recommendations and preventive measures to reduce dermatolymphangioadenitis HERE.



Despite the fact that lymphedema is not a difficult disease to diagnose or manage, many patients are untreated or even undertreated with low-cost ineffective methods. Lymphedema is easily managed, in the majority of cases, with adequate lymphatic therapy (Complete Decongestive Therapy). Read more about why elephantiasis is a forgotten and neglected disease HERE.



Complete Decongestive Therapy (CDT) is not limited to lymphedema stages I and II, but even late Stage III lymphedema (elephantiasis), improving greatly with good results in the majority of cases, thus preventing the need for debulking techniques. Radical reductive ablative surgery (Charles Procedure), aimed to remove the diseased skin and subcutaneous tissue, should always be the last option, for it is frequently associated with significant blood loss, morbidity, infections, permanent disfigurement, and recurrence of symptoms. Read more about the best treatment for lymphedema HERE.



Globally, health literacy concerning lymphatic vascular disease among healthcare workers is low. Misconceptions about preventive measures and the causes leading to the elephantiasis stage are common among healthcare providers. There are mistaken yet widespread beliefs that elephantiasis is of sudden onset, that it is only related to filariasis, or that it is not the result of undertreatment of lymphedema. Clearly, health care is held back as a result of inadequacies in both training and resources. Read more about the difference between elephantiasis and lymphatic Filariasis HERE.


CONCLUSION

Many health systems, even at the European level, are weak and under-resourced due to their low gross domestic product spent on health care. These countries only have the capacity to provide care to part of the population, and with a disproportionate share of funding focused on health care for very severe cases, and thus to the detriment of the patients suffering mild, moderate, and severe chronic lymphedema. Very few national Health systems advocate for the integration of lymphedema into the National Plans. Some promise to introduce lymphedema management services into government clinics and improve staff training, but many systems lack resources. Read about the country that provides the best treatment coverage for lymphedema HERE.






IMPORTANT NOTICE 

Lymphedema is a serious chronic and progressive disease due to lymphatic dysfunction (Organic Lymphatic Vascular Disease). The clinical treatment of lymphedema is neither a cosmetic nor an aesthetic treatment. The treatment of lymphedema is to control its progression and alleviate the symptoms related to dysfunction of the lymphatic circulatory system. 

To prevent and avoid serious complications associated with treatment, such as the possible displacement of edema to previously unaffected areas when compression therapy is applied for volume reduction, patients should use highly specialized and experienced therapists. Professional qualification and instruction delivered remotely online are not the same as live hands-on practical instruction in the clinical training and certification of lymphedema therapists, similar to all other rehabilitation, medical, and surgical training programs, and especially for developing the necessary manual skills to treat a disease as complex as lymphedema. 

Patients should also take special care when choosing a Multidisciplinary Expertise Center of Reference/Excellence for Lymphedema, as not all countries and centers provide the same treatment options. The best choice is a center of reference that provides Complete Decongestive Therapy (CDT), which is recognized as the Gold Standard treatment for lymphedema.

  • Read about what are the principal functions of Manual Lymphatic Drainage HERE.
  • Read about the differences between the two principal lymphedema treatment protocols HERE. 
  • Read about what are the strategies for the implementation of low-cost treatment options for Lymphedema HERE.

REFERENCES

(Click on the texts to read the research articles)

SCIENTIFIC SOCIETIES

PATHOPHYSIOLOGY

CUTANEOUS COMPLICATIONS
INFECTIOUS COMPLICATIONS
CELLULITIS / DERMATOLYMPHANGIOADENITIS
TUMOURS

TREATMENT

COMPRESSION GARMENTS

DISABILITY

DISFIGUREMENT

PSYCHOSOCIAL IMPACT

PEDIATRIC LYMPHEDEMA

LYMPHATIC FILARIASIS / PODOCONIOSIS



Articles that may also interest you: 
(Click on the texts)

    WHAT KIND OF DOCTOR TREATS LYMPHEDEMA/LYMPHOEDEMA - WHICH MEDICAL SPECIALITIES ARE RELATED TO LYMPHEDEMA?








































CLICK ON THE TEXTS
FOR LYMPHEDEMA INCIDENCE
AND PREVALENCE






Print this post